2022: The MILESTONE YEAR

Jetex Annual Review Dubai, United Arab Emirates, Dec. 29, 2022 (GLOBE NEWSWIRE) — The business aviation industry is currently going through the biggest transition in history, accelerated by the digitalisation, accessibility, and the exceptional travel conveniences that it offers against the backdrop of a gradual recovery from the health crisis. In many ways, it reflects […]

2022: The MILESTONE YEAR Read More

Abel Noser Finishes Year with an Impressive List of Achievements

Highlights Include New Product Launches, Numerous Industry Partnerships, and a Ramping Up of Trade Surveillance Services New York, NY, Dec. 29, 2022 (GLOBE NEWSWIRE) — Abel Noser Holdings, the market leader in institutional trade analytics and agency-only trading solutions, has many notable achievements to look back on this year as 2022 comes to a close. […]

Abel Noser Finishes Year with an Impressive List of Achievements Read More

Junshi Biosciences Announces NEJM Publication of Results of Phase 3 Study of VV116 Versus PAXLOVID for Adults at High Risk for Progression to Severe COVID-19

SHANGHAI, China, Dec. 29, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, today announces the online publication in New England Journal (NEJM) of the Phase 3 trial (NCT05341609) comparing the efficacy and safety […]

Junshi Biosciences Announces NEJM Publication of Results of Phase 3 Study of VV116 Versus PAXLOVID for Adults at High Risk for Progression to Severe COVID-19 Read More